Short multi-repeat rna targeting gene silencing
US-2024182899-A1 · Jun 6, 2024 · US
US9428757B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9428757-B2 |
| Application number | US-201013393063-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 27, 2010 |
| Priority date | Aug 31, 2009 |
| Publication date | Aug 30, 2016 |
| Grant date | Aug 30, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention in principle pertains to the field of recombinant manufacture of fatty acids. It provides novel nucleic acid molecules comprising nucleic acid sequences encoding fatty acid desaturases, elongases, acyltransferases, terminator sequences and high expressing seed-specific promoters operatively linked to the said nucleic acid sequences wherein nucleic acid expression enhancing nucleic acids (NEENAs) are functionally linked to said promoters.
Opening claim text (preview).
The invention claimed is: 1. A polynucleotide comprising: a) at least one nucleic acid sequence encoding a polypeptide having desaturase or elongase activity; b) at least one seed-specific plant promoter operatively linked to the nucleic acid sequence of a); c) at least one terminator sequence operatively linked to the nucleic acid sequence of a); and d) at least one nucleic acid expression enhancing nucleic acid (NEENA) molecule functionally linked to the promoter of b), wherein said at least one NEENA molecule is heterologous to the promoter of b) and to the polypeptide of a), wherein said at least one NEENA molecule comprises a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24, wherein said at least one NEENA molecule is not able to drive expression of the nucleic acid sequence of a) but is able to enhance expression of said nucleic acid sequence when functionally linked to the promoter of b), and wherein said at least one NEENA molecule enhances seed-specific expression of said nucleic acid sequence of a) in the plant or part thereof as compared to a corresponding control plant or part thereof. 2. The polynucleotide of claim 1 , comprising: e) at least one nucleic acid sequence encoding a polypeptide having beta-ketoacyl reductase activity; f) at least one nucleic acid sequence encoding a polypeptide having dehydratase activity; and/or g) at least one nucleic acid sequence encoding a polypeptide having enoyl-CoA reductase activity, wherein the nucleic acid sequences of e) to g) are heterologous to said polypeptide having desaturase or elongase activity. 3. The polynucleotide of claim 2 , comprising at least one nucleic acid sequence encoding a polypeptide having acyltransferase activity, wherein the nucleic acid sequence is heterologous to said polypeptide having desaturase, elongase, beta-ketoacyl reductase, dehydratase, or enoyl-CoA reductase activity. 4. A vector comprising the polynucleotide of claim 1 . 5. A host cell comprising: a) the polynucleotide of claim 1 ; or b) a vector comprising said polynucleotide. 6. A method for the manufacture of a polypeptide encoded by the polynucleotide of claim 1 , comprising: a) cultivating a host cell comprising the polynucleotide of claim 1 or a vector comprising said polynucleotide under conditions which allow for the production of the polypeptide; and b) obtaining the polypeptide from the host cell. 7. A non-human transgenic organism comprising the polynucleotide of claim 1 or a vector comprising said polynucleotide. 8. The non-human transgenic organism of claim 7 , which is a plant or a plant part. 9. A method for the manufacture of polyunsaturated fatty acids comprising: a) cultivating the host cell of claim 5 under conditions which allow for the production of polyunsaturated fatty acids in said host cell; and b) obtaining said polyunsaturated fatty acids from the host cell. 10. A method for the manufacture of polyunsaturated fatty acids comprising: a) cultivating the non-human transgenic organism of claim 7 under conditions which allow for the production of a polyunsaturated fatty acid in said non-human transgenic organism; and b) obtaining said polyunsaturated fatty acid from the non-human transgenic organism. 11. The method of claim 9 , wherein said polyunsaturated fatty acid is arachidonic acid (ARA), eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA). 12. A method for the manufacture of an oil, lipid, or fatty acid composition comprising: a) cultivating the host cell of claim 5 under conditions which allow for the production of a polyunsaturated fatty acid in said host cell; b) obtaining said polyunsaturated fatty acid from said host cell; and c) formulating said polyunsaturated fatty acid as an oil, lipid, or fatty acid composition. 13. A method for the production of foodstuffs, animal feed, a seed, a pharmaceutical, or a fine chemical, comprising: a) providing the host cell of claim 5 , or a host cell culture, non-human transgenic organism, transgenic plant, plant part, or plant seed derived from a transgenic non-human organism or plant comprising said host cell; and b) preparing foodstuffs, animal feed, a seed, a pharmaceutical, or a fine chemical. 14. A method for enhancing expression of at least one enzyme of the polyunsaturated fatty acid biosynthetic pathway in a plant or part thereof, comprising transforming a plant or part thereof with a polynucleotide comprising: i) at least one nucleic acid sequence encoding a polypeptide selected from the group consisting of: a) a polypeptide having desaturase or elongase activity; b) a polypeptide having beta-ketoacyl reductase activity; c) a polypeptide having dehydratase activity; and d) a polypeptide having enoyl-CoA reductase activity; ii) at least one seed-specific plant promoter operatively linked to the nucleic acid sequence of i); iii) at least one terminator sequence operatively linked to the nucleic acid sequence of i); and iv) at least one nucleic acid expression enhancing nucleic acid (NEENA) molecule functionally linked to the promoter of ii), wherein said at least one NEENA molecule is heterologous to the promoter of ii) and to the nucleic acid sequence of i), wherein said at least one NEENA molecule comprises a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24, wherein said at least one NEENA molecule is not able to drive expression of the nucleic acid sequence of i) but is able to enhance expression of said nucleic acid sequence when functionally linked to the promoter of ii), and wherein said at least one NEENA molecule enhances seed-specific expression of said nucleic acid sequence of i) in the plant or part thereof as compared to a corresponding control plant or part thereof. 15. The method of claim 14 , wherein said at least one NEENA molecule comprises the nucleotide sequence of SEQ ID NO: 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24. 16. The polynucleotide of claim 1 , wherein said at least one NEENA molecule comprises the nucleotide sequence of SEQ ID NO: 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24.
Methods for controlling, regulating or enhancing expression of transgenes in plant cells · CPC title
involving modified lipid metabolism, e.g. seed oil composition · CPC title
Seed-specific, e.g. embryo, endosperm · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.